If we are to do boosters, once the immunocompromised have been 3rd dosed we should seriously consider vaccinating certain high transmission groups (network nodes) - benefits of focussed & timely transmission reduction might outweigh alternative options.
Anyone know of any published modelling for this?
(I recognise importance of total take up over probably anything else).
Of course, how to (or whether its possible to properly) identify, and then efficiently vaccinate, those high transmission groups remains key:

I guess my point is just that, if VE against severe disease unlikely to have waned significantly thelancet.com/journals/lance… (for now), but immunity against infection/transmission does/has,
the 10s of millions of vaccine doses we are (likely) to give to 'boost' immunity *may* provide greater overall PH benefit if given tactically in an attempt to suppress the winter wave, rather than just by age group in descending order.
Of course, very many variables here, and certainly I acknowledge that even without any potential waning VE in older people is lower , and so possibly is best to, if 'boosting', just do so by direct medical risk.
Also ofc much would depend on ability to optimise timing of response against nAb waning
and, as said, actually identifying those high transmission groups.
Another factor ofc is those groups Delta infection/recovery status (likely many in high transmission groups have already had Delta, so third vax of reduced benefit here both in terms of any additional individual protection and network transmission reduction..).
But, for instance, in the initial scale-up of vaccine roll-out many key workers, including younger people, were offered and vaccinated at scale with 'spare' doses.
These are groups with (likely) higher than avg contact rates, so benefits to be had if they have high levels of nAbs through winter, and their vaccine induced immunity against infection/transmission waning as vaccinated earliest
Arguably (recognising this is just my 'logical' thinking rather than systematic modelling) more population benefits to be had from 3rd dosing these groups over, say, a WFH 53 year old..
Not saying this is easy or the right answer, for sure, and difficult for JCVI/ministers to make decisions off a stream of thoughts or even hazy modelling over actual robust evidence and more certain and direct medical benefits,
but I do think if we are to give tens of millions of boosters, it is certainly worth serious consideration of what we want to, or can, achieve with these doses.
I've always been a believer that a more adaptive and tactical response can achieve considerably greater PH benefit:
- and the potential benefits of suppressing a winter COVID wave through effective and adaptive vaccination would be significant…
Much of this again comes down to what is within JCVI remit:

If they are not really able to consider potential for wider Public Health benefits of vaccination, are the decisions being made the most optimal from a Public Health perspective..?
Yesterday I found myself quite liking a system where JCVI assess direct medical benefits to individuals and then pass to CMOs to take a wider health and social (although still from an individual rather than population benefits vs risks) perspective.
But is such a process tuned to be able to realstically achieve an (IMO highly desirable) adaptive and tactical PH response..?
Ofc would also have to consider if, in younger people, side-effects outweigh/marginalise any benefit against infection/disease whether it is appropriate to boost these groups w/ only uncertain benefits to population..
But again though, all comes back to how we *make* decisions - are we sure current approach is the optimal decision-making *process* (not just decision) for society and the collective Public Health of the UK..?

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with The Sharing Scientist

The Sharing Scientist Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ScienceShared

13 Sep
Remi Joseph-Salisbury, another of the report’s authors, said:

‘The evidence in this report really urges us to question the State’s reliance on the police to solve social and public health problems.
Despite being central to the government’s handling of the pandemic, policing too often threatens rather than protects public safety, particularly for people of colour.’
Liz Fekete, Director of the IRR said:

‘This research gives a voice to those who have had uncivil, discriminatory or brutal encounters with the police and points to the dangers that the public health model poses for “policing by consent”.
Read 6 tweets
13 Sep
The four chief medical officers for the UK have recommended that all children aged 12 to 15 years old should be offered one dose of the Pfizer Covid vaccine.

The decision comes after scientific advisers serving on the Joint Committee for Vaccination and Immunisation (JCVI) said the vaccine only offered a "marginal" health benefit for that age group and could not be recommended on health grounds alone.
The CMOs said the decision was based primarily on the impact on education for that age group.

They considered the physical and mental health and long-term prospects for children in that age group.
Read 7 tweets
14 Aug
One thing I don't actually personally buy is the argument that we must 'vaccinate the world to mitigate the development of new variants.'

Yes, vaccine-induced immunity places downward pressure on transmission, which means less chances for the virus to replicate, & mutate..

But high vaccine coverage also means governments may/can decide that transmission is now less of a problem, and therefore doesn't need to be suppressed with NPIs to the same extent as pre-vaccination (see Denmark & other gov statements (not just UK))..
In this scenario, mass vax reduces morbidity & mortality, but policy changes following increased protection may increase transmission: replication & potential for mutation can/will be high.

Spread may/will also reach immunocompromised patients, where VOCs may emerge.
Read 7 tweets
13 Aug
Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis

• Symptomology data demonstrate real-world use of LFDs beyond asymptomatic screening

• LFDs facilitated detection of COVID-19 infected individuals with atypical symptoms

• LFDs enabled isolation of infected individuals prior to classical symptom onset
Another, of many, studies which imo support shifting to symptomatic LFD testing - testing for a fuller, more relevant, range of symptoms can reduce transmission & associated morbidity, mortality, & socioeconomic disruption in a more cost-effective manner

Read 4 tweets
11 Aug
I will say - I imagine measuring secreted Abs in nose/throat (the mucosal immune response potentially relevant in reducing infectiousness of shedded virions) is difficult (largely due to variability within assays).

Therefore, imho the absence of correlation between nAbs and peak viral loads identified here, and following suggestions that vaccination may not lower the infectivity of 'breakthrough' infections, are not certain to be 'true.'

Read 6 tweets
10 Aug
A neat article by @devisridhar in The Guardian..

''We made sacrifices to buy time for a scientific solution that has now arrived.''

''While life hasn’t returned to pre-Covid normality, it is nonetheless time to start getting back to living.''

''Now even the countries that pursued ZeroCOVID, such as Aus & NZ, need a more sustainable strategy. This will involve vaccinating 80-90% of their populations and opening up cautiously to itl travel. All countries are running towards the same goal: mass vaccination coverage.''
''There are still questions over what will happen this winter in the UK and Europe. But the problems we may face in the future will pale in comparison to the devastation that Delta is causing in countries such as Peru, Namibia, Indonesia and Nepal.''
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!